These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Cost-Effectiveness Methods and Newborn Screening Assessment. Castilla-Rodríguez I; Vallejo-Torres L; Couce ML; Valcárcel-Nazco C; Mar J; Serrano-Aguilar P Adv Exp Med Biol; 2017; 1031():267-281. PubMed ID: 29214578 [TBL] [Abstract][Full Text] [Related]
3. Clinical effectiveness and cost-effectiveness of neonatal screening for inborn errors of metabolism using tandem mass spectrometry: a systematic review. Pandor A; Eastham J; Beverley C; Chilcott J; Paisley S Health Technol Assess; 2004 Mar; 8(12):iii, 1-121. PubMed ID: 14982654 [TBL] [Abstract][Full Text] [Related]
4. An Economic Evaluation of Neonatal Screening for Inborn Errors of Metabolism Using Tandem Mass Spectrometry in Thailand. Thiboonboon K; Leelahavarong P; Wattanasirichaigoon D; Vatanavicharn N; Wasant P; Shotelersuk V; Pangkanon S; Kuptanon C; Chaisomchit S; Teerawattananon Y PLoS One; 2015; 10(8):e0134782. PubMed ID: 26258410 [TBL] [Abstract][Full Text] [Related]
5. Projected cost-effectiveness of statewide universal newborn hearing screening. Keren R; Helfand M; Homer C; McPhillips H; Lieu TA Pediatrics; 2002 Nov; 110(5):855-64. PubMed ID: 12415021 [TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness of expanded newborn screening in Texas. Tiwana SK; Rascati KL; Park H Value Health; 2012; 15(5):613-21. PubMed ID: 22867769 [TBL] [Abstract][Full Text] [Related]
7. The Use of Economic Evaluation to Inform Newborn Screening Policy Decisions: The Washington State Experience. Grosse SD; Thompson JD; Ding Y; Glass M Milbank Q; 2016 Jun; 94(2):366-91. PubMed ID: 27265561 [TBL] [Abstract][Full Text] [Related]
8. Cost-Effectiveness Analysis of a National Newborn Screening Program for Biotinidase Deficiency. Vallejo-Torres L; Castilla I; Couce ML; Pérez-Cerdá C; Martín-Hernández E; Pineda M; Campistol J; Arrospide A; Morris S; Serrano-Aguilar P Pediatrics; 2015 Aug; 136(2):e424-32. PubMed ID: 26169436 [TBL] [Abstract][Full Text] [Related]
9. Neonatal screening for inborn errors of metabolism: cost, yield and outcome. Pollitt RJ; Green A; McCabe CJ; Booth A; Cooper NJ; Leonard JV; Nicholl J; Nicholson P; Tunaley JR; Virdi NK Health Technol Assess; 1997; 1(7):i-iv, 1-202. PubMed ID: 9483160 [TBL] [Abstract][Full Text] [Related]
10. Newborn screening for inborn errors of metabolism: a systematic review. Seymour CA; Thomason MJ; Chalmers RA; Addison GM; Bain MD; Cockburn F; Littlejohns P; Lord J; Wilcox AH Health Technol Assess; 1997; 1(11):i-iv, 1-95. PubMed ID: 9483156 [TBL] [Abstract][Full Text] [Related]
12. Health economic analysis of the neonatal screening program in Japan. Hisashige A Int J Technol Assess Health Care; 1994; 10(3):382-91. PubMed ID: 8071001 [TBL] [Abstract][Full Text] [Related]
13. [The metabolic newborn screening as a healthcare model of the precision medicine. Perspective from the Spanish Association for the Study of Congenital Errors of Metabolism (AECOM).]. González-Lamuño Leguina D; Bóveda Fontán MD; Bueno Delgado M; Gort Mas L; Unceta Suárez M; Morales Conejo M Rev Esp Salud Publica; 2021 Jan; 95():. PubMed ID: 33496277 [TBL] [Abstract][Full Text] [Related]
14. Cost effectiveness of establishing a neonatal screening programme for phenylketonuria in Libya. Sladkevicius E; Pollitt RJ; Mgadmi A; Guest JF Appl Health Econ Health Policy; 2010; 8(6):407-20. PubMed ID: 21043542 [TBL] [Abstract][Full Text] [Related]
15. Cost and cost-effectiveness of universal screening for hearing loss in newborns. Kezirian EJ; White KR; Yueh B; Sullivan SD Otolaryngol Head Neck Surg; 2001 Apr; 124(4):359-67. PubMed ID: 11283492 [TBL] [Abstract][Full Text] [Related]
16. Pulse oximetry as a screening test for congenital heart defects in newborn infants: a test accuracy study with evaluation of acceptability and cost-effectiveness. Ewer AK; Furmston AT; Middleton LJ; Deeks JJ; Daniels JP; Pattison HM; Powell R; Roberts TE; Barton P; Auguste P; Bhoyar A; Thangaratinam S; Tonks AM; Satodia P; Deshpande S; Kumararatne B; Sivakumar S; Mupanemunda R; Khan KS Health Technol Assess; 2012; 16(2):v-xiii, 1-184. PubMed ID: 22284744 [TBL] [Abstract][Full Text] [Related]
17. [Half a century of newborn screening in Spain: Evolution of ethical, legal and social issues (ELSIs). Part III, social issues.]. Labrador Cañadas MV; Pàmpols Ros T; Dulín Íñiguez E; Pérez Aytés A; García Sagredo JM; Díaz de Bustamante A; Martín Arribas C; García López FJ; Nicolás Jiménez P Rev Esp Salud Publica; 2021 Jan; 95():. PubMed ID: 33496273 [TBL] [Abstract][Full Text] [Related]
18. Cost analysis: concepts and application. Brosnan CA; Swint JM Public Health Nurs; 2001; 18(1):13-8. PubMed ID: 11251868 [TBL] [Abstract][Full Text] [Related]
19. Newborn screening by tandem mass spectrometry for medium-chain Acyl-CoA dehydrogenase deficiency: a cost-effectiveness analysis. Venditti LN; Venditti CP; Berry GT; Kaplan PB; Kaye EM; Glick H; Stanley CA Pediatrics; 2003 Nov; 112(5):1005-15. PubMed ID: 14595039 [TBL] [Abstract][Full Text] [Related]